HIV study probes hidden clot risks
NCT ID NCT00776412
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 5 times
Summary
This study looked at markers of inflammation, blood clotting, and blood vessel function in 310 HIV-infected adults and healthy volunteers. Researchers collected blood samples to understand how these markers relate to HIV and risks like heart disease or stroke. The goal was to gather information for future studies, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- Could a stress hormone be behind the hidden danger of low blood sugar?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?
- Grape powder may help aging immune systems — a trial puts it to the test
- Can a new strategy break the cycle of HIV care dropout?